Tag: Parkinson's disease

ABL Bio, Sanofi sign $1bn deal for Parkinson’s candidate ABL301

businessnewstoday- January 14, 2022 0

ABL Bio has bagged a global collaboration and licensing deal worth up to $1.06 billion with Sanofi to develop and commercialize its drug candidate ABL301 ... Read More

Lilly wraps up acquisition of gene therapy company Prevail Therapeutics

pharmanewsdaily- January 23, 2021 0

Eli Lilly and Company (Lilly) has completed its previously announced deal worth up to $1.04 billion of US gene therapy company Prevail Therapeutics. The US ... Read More

Lilly to acquire US gene therapy company Prevail Therapeutics in $1bn deal

pharmanewsdaily- December 16, 2020 0

Eli Lilly and Company (Lilly) has signed a deal worth up to $1.04 billion to acquire Prevail Therapeutics, a US gene therapy company engaged in ... Read More

Cerevel launches phase 3 Parkinson’s disease clinical trials for tavapadon

pharmanewsdaily- January 15, 2020 0

Parkinson’s disease clinical trials : Cerevel Therapeutics, a US biopharma company, has initiated a phase 3 clinical trial program for evaluating tavapadon in Parkinson’s disease ... Read More

resTORbio to stop RTB101 development for symptomatic respiratory illness

pharmanewsdaily- November 18, 2019 0

resTORbio has discontinued the development of RTB101, a TORC1 inhibitor, for the prevention of clinically symptomatic respiratory illness (CSRI) after the drug failed to meet ... Read More

Merck acquires Calporta Therapeutics from COI Pharmaceuticals

pharmanewsdaily- November 15, 2019 0

Merck acquisition of Calporta : Merck has acquired Calporta Therapeutics from COI Pharmaceuticals in a deal worth up to $576 million, as per the latest ... Read More

Amazing health benefits of Fava beans

pharmanewsdaily- April 16, 2019 0

Fava beans are the tiny, delicious, sweet, earthy flavor green legumes that grow as pods. Fava beans are a rich source of protein, fibre and ... Read More

Britannia Pharmaceuticals apomorphine infusion succeeds in TOLEDO trial

pharmanewsdaily- August 5, 2018 0

Phase 3 trial for apomorphine infusion : British pharma company Britannia Pharmaceuticals said that its APO-go/MOVAPO (apomorphine) subcutaneous infusion has succeeded in a phase 3 ... Read More

Danish pharma company Lundbeck to buy Parkinson’s drug developer Prexton

businessnewstoday- March 16, 2018 0

Pharma acquisition news : Danish pharma company Lundbeck has reached an agreement, expected to be worth around $1.1 billion, to acquire Prexton Therapeutics, a Swiss ... Read More

Ajanta Pharma gets USFDA approval for Entacapone, Parkinson’s disease tablet

pharmanewsdaily- September 4, 2017 0

Ajanta Pharma got the final USFDA approval for Entacapone tablets which is used for treating the Parkinson’s disease. Ajanta Pharma said that it has received ... Read More